Literature DB >> 11819006

Brainstem hemorrhage in descending transtentorial herniation (Duret hemorrhage).

Paul M Parizel1, Smitha Makkat, Philippe G Jorens, Ozkan Ozsarlak, Patrick Cras, Johan W Van Goethem, Luc van den Hauwe, Jan Verlooy, Arthur M De Schepper.   

Abstract

OBJECTIVES: To review clinical and radiological findings in patients with Duret hemorrhages and to discuss the pathophysiology and differential diagnosis of these lesions. PATIENTS AND METHODS: We reviewed the case records of four patients with Duret hemorrhages who had been admitted to the neurological intensive care unit with supratentorial mass lesions.
RESULTS: Descending transtentorial and subfalcine herniations were present in all cases. Three patients were admitted with acute subdural hematoma and one with intraparenchymal hemorrhage. Computed tomography revealed the presence of blood in the mesencephalon and upper pons. Three patients died; one survived with severe disabilities. DISCUSSION: Duret hemorrhages are typically located in the ventral and paramedian aspects of the upper brainstem (mesencephalon and pons). The pathophysiology of Duret hemorrhage remains under debate: arterial origin (stretching and laceration of pontine perforating branches of the basilar artery), versus venous origin (thrombosis and venous infarction). Multifactorial causation seems likely.
CONCLUSION: Duret hemorrhages are delayed, secondary brainstem hemorrhages. They occur in craniocerebral trauma victims with rapidly evolving descending transtentorial herniation. Diagnosis is made on computed tomography of the brain. In most cases the outcome is fatal. On the basis of our observations we believe that arterial hypertension and advanced age are risk factors for the development of Duret hemorrhage.

Entities:  

Mesh:

Year:  2001        PMID: 11819006     DOI: 10.1007/s00134-001-1160-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  9 in total

Review 1.  [Craniocerebral trauma. 2: Intra-axial injuries, secondary injuries].

Authors:  T Struffert; C Axmann; W Reith
Journal:  Radiologe       Date:  2003-11       Impact factor: 0.635

Review 2.  Emergency radiology eponyms: part 1-Pott's puffy tumor to Kerley B lines.

Authors:  Clint W Sliker; Scott D Steenburg; Krystal Archer-Arroyo
Journal:  Emerg Radiol       Date:  2012-10-16

3.  Dural venous sinuses distortion and compression with supratentorial mass lesions: a mechanism for refractory intracranial hypertension?

Authors:  Adnan I Qureshi; Mushtaq H Qureshi; Shahram Majidi; Waqas I Gilani; Farhan Siddiq
Journal:  J Vasc Interv Neurol       Date:  2014-05

4.  Ultra-early aneurysmal rebleeding and brainstem destruction.

Authors:  Jennifer E Fugate; Grant W Mallory; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

5.  Duret hemorrhage: demonstration of ruptured paramedian pontine branches of the basilar artery on minimally invasive, whole body postmortem CT angiography.

Authors:  Ka Lip Chew; Yeliena Baber; Linda Iles; Christopher O'Donnell
Journal:  Forensic Sci Med Pathol       Date:  2012-04-07       Impact factor: 2.007

Review 6.  New developments in the neuroradiological diagnosis of craniocerebral trauma.

Authors:  P M Parizel; J W Van Goethem; O Ozsarlak; M Maes; C D Phillips
Journal:  Eur Radiol       Date:  2005-02-05       Impact factor: 5.315

Review 7.  Neurologic Emergencies in the Patients With Cancer.

Authors:  Andrew L Lin; Edward K Avila
Journal:  J Intensive Care Med       Date:  2016-07-09       Impact factor: 3.510

8.  Good outcomes in a patient with a Duret hemorrhage from an acute subdural hematoma.

Authors:  Ha Son Nguyen; Ninh B Doan; Michael J Gelsomino; Saman Shabani; Wade M Mueller
Journal:  Int Med Case Rep J       Date:  2016-01-27

9.  Recovery of Functional Independence After Traumatic Transtentorial Herniation With Duret Hemorrhages.

Authors:  Brian L Edlow; Zachary D Threlkeld; Katie P Fehnel; Yelena G Bodien
Journal:  Front Neurol       Date:  2019-10-09       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.